Brazil

Mantecorp Industria Quimica e Farmaceutica S.A.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 19.99 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Portuguese Format: PDF Download Most recent financial data: 2005 Buy full report

What’s included?

This report extracts all available information about Mantecorp Industria Quimica e Farmaceutica S.A. from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
Est dos Bandeirantes 3091 - Taquara
Rio de Janeiro; Rio de Janeiro; Map
Postal Code: 22775-111

Tel: +55 21 21263111 / 21263066 / 21263000 / 21263011 / 2126
Fax: +55 21 3342-

Email:
@hypermarcas.com.br

Website:
http://www.afrin.com.br

Company Description
Mantecorp was formed in 2006 as an independent organization, after 17 years of partnership with North American Schering-Plough. The company has six product lines - Respiratory, Dermatology, Central Nervous System, Pediatric, Orthopedics, Gynecological and Obstetric. It also works in the Biotechnological segment, which deals with drugs for the treatment of diseases of high complexity, and the Medicines Exempted from prescription.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
630 (2012)
Incorporation Date:
August 08, 1966
Profile Updated:
July 09, 2015
Key Executives
Director
Key Financial Highlights
No results were found for this company.
Top Competitors

Financial Statements

Annual Statements
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO